N6-methyladenosine-mediated upregulation of H19 promotes resistance to bortezomib by modulating the miR-184/CARM1 axis in multiple myeloma. - Wang G; Wu W; He D; Wang J; Kong H (Clinical and experimental medicine, 2025)